Literature DB >> 15221975

Serum linoleic and total polyunsaturated fatty acids in relation to prostate and other cancers: a population-based cohort study.

David E Laaksonen1, Jari A Laukkanen, Leo Niskanen, Kristiina Nyyssönen, Tiina H Rissanen, Sari Voutilainen, Eero Pukkala, Anna Hakkarainen, Jukka T Salonen.   

Abstract

Dietary and serum fatty acid composition has been implicated in the pathogenesis of prostate and other cancers, but findings have been conflicting. Cohort studies reporting serum fatty acid composition are lacking. We assessed the association of fatty acid composition determined from dietary records and serum with incident cancer of the prostate and any site in a population-based cohort of 2,002 middle-aged Finnish men who were free of cancer at baseline and during the first 4 years of follow-up. During 12.6 years of follow-up, 46 men developed prostate cancer and 151 any cancer. Men with proportions of serum nonesterified [risk ratio (RR) 0.28; 95% confidence intervals (CI) 0.12-0.66] and esterified linoleic acid (RR 0.37; 95% CI = 0.16-0.86) and total polyunsaturated fatty acids (RR 0.30; 95% CI = 0.12-0.71) in the upper third were less than 1/3 as likely to develop prostate cancer during follow-up. Adjustment for possible confounders like socioeconomic status, physical activity, obesity and insulin concentrations did not attenuate the association. Similar but weaker associations with any cancer were found. Dietary linoleic acid intake also tended to be inversely associated with incident prostate cancer (age-adjusted RR for the upper vs. lower third 0.55; 95% CI = 0.26-1.14, p for the trend 0.097). Substitution of linoleic acid for saturated fat in middle-aged men consuming a high saturated-fat diet may decrease the risk of prostate and other cancers, although it is possible that some of the effect may be mediated by nutrients closely associated with vegetable fats. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15221975     DOI: 10.1002/ijc.11614

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  Serum phospholipid fatty acids and prostate cancer risk: results from the prostate cancer prevention trial.

Authors:  Theodore M Brasky; Cathee Till; Emily White; Marian L Neuhouser; Xiaoling Song; Phyllis Goodman; Ian M Thompson; Irena B King; Demetrius Albanes; Alan R Kristal
Journal:  Am J Epidemiol       Date:  2011-04-24       Impact factor: 4.897

2.  Blood fatty acid patterns are associated with prostate cancer risk in a prospective nested case-control study.

Authors:  Meng Yang; Azalea Ayuningtyas; Stacey A Kenfield; Howard D Sesso; Hannia Campos; Jing Ma; Meir J Stampfer; Jorge E Chavarro
Journal:  Cancer Causes Control       Date:  2016-08-03       Impact factor: 2.506

3.  The effects of body mass index on changes in prostate-specific antigen levels and prostate volume over 15 years of follow-up: implications for prostate cancer detection.

Authors:  Lauren P Wallner; Hal Morgenstern; Michaela E McGree; Debra J Jacobson; Jennifer L St Sauver; Steven J Jacobsen; Aruna V Sarma
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-01-17       Impact factor: 4.254

Review 4.  Omega-3 fatty acids, genetic variants in COX-2 and prostate cancer.

Authors:  Adam C Reese; Vincent Fradet; John S Witte
Journal:  J Nutrigenet Nutrigenomics       Date:  2009-09-23

5.  A 22-y prospective study of fish intake in relation to prostate cancer incidence and mortality.

Authors:  Jorge E Chavarro; Meir J Stampfer; Megan N Hall; Howard D Sesso; Jing Ma
Journal:  Am J Clin Nutr       Date:  2008-11       Impact factor: 7.045

6.  Circulating fatty acids and prostate cancer risk in a nested case-control study: the Multiethnic Cohort.

Authors:  Song-Yi Park; Lynne R Wilkens; Susanne M Henning; Loïc Le Marchand; Kun Gao; Marc T Goodman; Suzanne P Murphy; Brian E Henderson; Laurence N Kolonel
Journal:  Cancer Causes Control       Date:  2008-09-27       Impact factor: 2.506

7.  Plasma Fatty Acids as Surrogate for Prostate Levels.

Authors:  Jeannette M Schenk; Xiaoling Song; Colm Morrissey; Robert L Vessella; Daniel W Lin; Marian L Neuhouser
Journal:  Nutr Cancer       Date:  2017-12-21       Impact factor: 2.900

8.  Effect Modification by Time Since Blood Draw on the Association Between Circulating Fatty Acids and Prostate Cancer Risk.

Authors:  Meng Yang; Howard D Sesso; Graham A Colditz; Jing Ma; Meir J Stampfer; Jorge E Chavarro
Journal:  J Natl Cancer Inst       Date:  2016-06-13       Impact factor: 13.506

9.  Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.

Authors:  Theodore M Brasky; Amy K Darke; Xiaoling Song; Catherine M Tangen; Phyllis J Goodman; Ian M Thompson; Frank L Meyskens; Gary E Goodman; Lori M Minasian; Howard L Parnes; Eric A Klein; Alan R Kristal
Journal:  J Natl Cancer Inst       Date:  2013-07-10       Impact factor: 13.506

10.  Relationship of dietary intake of omega-3 and omega-6 Fatty acids with risk of prostate cancer development: a meta-analysis of prospective studies and review of literature.

Authors:  Michael E Chua; Maria Christina D Sio; Mishell C Sorongon; Jun S Dy
Journal:  Prostate Cancer       Date:  2012-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.